chr9-87637937-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_004938.4(DAPK1):c.285-6T>C variant causes a splice region, splice polypyrimidine tract, intron change. The variant allele was found at a frequency of 0.00121 in 1,613,406 control chromosomes in the GnomAD database, including 22 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0064 ( 12 hom., cov: 33)
Exomes 𝑓: 0.00067 ( 10 hom. )
Consequence
DAPK1
NM_004938.4 splice_region, splice_polypyrimidine_tract, intron
NM_004938.4 splice_region, splice_polypyrimidine_tract, intron
Scores
2
Splicing: ADA: 0.0001138
2
Clinical Significance
Conservation
PhyloP100: 4.87
Genes affected
DAPK1 (HGNC:2674): (death associated protein kinase 1) Death-associated protein kinase 1 is a positive mediator of gamma-interferon induced programmed cell death. DAPK1 encodes a structurally unique 160-kD calmodulin dependent serine-threonine kinase that carries 8 ankyrin repeats and 2 putative P-loop consensus sites. It is a tumor suppressor candidate. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 9-87637937-T-C is Benign according to our data. Variant chr9-87637937-T-C is described in ClinVar as [Benign]. Clinvar id is 713719.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00645 (982/152316) while in subpopulation AFR AF= 0.0228 (950/41580). AF 95% confidence interval is 0.0216. There are 12 homozygotes in gnomad4. There are 469 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 982 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DAPK1 | NM_004938.4 | c.285-6T>C | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000408954.8 | NP_004929.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DAPK1 | ENST00000408954.8 | c.285-6T>C | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 2 | NM_004938.4 | ENSP00000386135 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00644 AC: 980AN: 152198Hom.: 12 Cov.: 33
GnomAD3 genomes
AF:
AC:
980
AN:
152198
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00166 AC: 414AN: 249236Hom.: 3 AF XY: 0.00112 AC XY: 151AN XY: 135232
GnomAD3 exomes
AF:
AC:
414
AN:
249236
Hom.:
AF XY:
AC XY:
151
AN XY:
135232
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000667 AC: 974AN: 1461090Hom.: 10 Cov.: 31 AF XY: 0.000534 AC XY: 388AN XY: 726768
GnomAD4 exome
AF:
AC:
974
AN:
1461090
Hom.:
Cov.:
31
AF XY:
AC XY:
388
AN XY:
726768
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00645 AC: 982AN: 152316Hom.: 12 Cov.: 33 AF XY: 0.00630 AC XY: 469AN XY: 74482
GnomAD4 genome
AF:
AC:
982
AN:
152316
Hom.:
Cov.:
33
AF XY:
AC XY:
469
AN XY:
74482
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
5
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 09, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at